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a b s t r a c t
Actin ﬁlaments are known to play a central role in cellular dynamics. After polymerization of actin,
various actin-crosslinking proteins including non-muscle myosin II facilitate the formation of spatially
organized actin ﬁlament networks. The actin-myosin network is highly expanded beneath plasma
membrane. The genome of inﬂuenza virus (vRNA) replicates in the cell nucleus. Then, newly synthesized
vRNAs are nuclear-exported to the cytoplasm as ribonucleoprotein complexes (vRNPs), followed by
transport to the beneath plasma membrane where virus particles assemble. Here, we found that, by
inhibiting actin-myosin network formation, the virus titer tends to be reduced and HA viral spike protein
is aggregated on the plasma membrane. These results indicate that the actin-myosin network plays an
important role in the virus formation.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Actin ﬁlaments play essential roles in cytokinesis, cell motility,
cell adhesion, and formation of membrane architecture (Diz-Muñoz
et al., 2013; Giannone et al., 2007; Mishra et al., 2013). The core
component of the actin ﬁlaments is monomeric actin that self-
assembles into ﬁlamentous actin. A various actin-crosslinking pro-
teins facilitate the formation of spatially-organized networks of actin
ﬁlaments. Among these proteins, non-muscle myosin II (NMII) is
known to be a crucial factor for the fundamental actin dynamics.
NMII is a motor protein consisting of two identical heavy chains and
two pairs of light chains. The heavy chains are subunits forming
bipolar ﬁlaments for self-association of NMII through the interaction
in an anti-parallel manner (Conti and Adelstein, 2008). Through the
heavy chains, NMII binds to and walks along the actin ﬁlaments in
its ATPase activity-dependent manner. The actin-myosin network is
highly expanded beneath the plasma membrane, where a variety of
membrane morphogenesis events occur, including receptor clust-
ering, membrane protrusion and secretion (Chichili and Rodgers,
2009; Goswami et al., 2008; Jaqaman et al., 2011; Lillemeier et al.,
2006; Papadopulos et al., 2013; Porat-Shliom et al., 2013; Vicente-
Manzanares et al., 2007).
It has been known that a variety of viruses utilize cellular
cytoskeleton for their efﬁcient replication. After the attachment
of viruses to the cell surface, viruses such as human immuno-
deﬁciency virus (HIV), vesicular stomatitis virus, and vaccinia
virus, move along cellular ﬁlopodia and microvilli toward the
cell body, which is called “virus surﬁng”. The actin-myosin
network located beneath the plasma membrane mediates this
movement (Lehmann et al., 2005; Mercer and Helenius, 2008).
The virus surﬁng makes virions move toward the entry site on
the plasma membrane, where endocytosis regulated by the
actin-myosin network for virus entry occurs. Microtubules are
generally exploited for a long-distance transport. It is known
that microtubules and kinesin motor protein KIF4 serve to
transport Gag proteins of retroviruses to the plasma membrane
(Tang et al., 1999). Subsequently, the assembly and budding of
HIV-1 occur in a lipid raft-dependent manner, which is regu-
lated by underlying actin ﬁlaments as well as microtubules
(Jolly et al., 2007).
The inﬂuenza viral genome (vRNA) consists of eight single-stra-
nded RNA segments of negative polarity. These vRNA segments exist
as ribonucleoprotein complexes (vRNPs) with viral RNA-dependent
RNA polymerases and nucleoprotein (NP). After attachment of
virions to host cells, vRNPs are released into the cytoplasm through
uncoating process of virions. Then, vRNPs translocate to the nucleus,
where transcription and replication of the virus genome occur. At
late phases of infection, newly synthesized vRNPs are exported to
the cytoplasm and transported to the apical plasma membrane.
Consequently, vRNPs are enveloped by the plasma membrane
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Fig. 1. Effects of inhibitors and siRNA for actin cytoskeleton on inﬂuenza virus replication. In panels A, B, and C, MDCK cells were infected with PR8 virus at an MOI of 3. The cells
were untreated (lane 1) or treated with 10, 33, or 100 μM of CytoD (lanes 2 to 4), or 5, 15, 50, or 150 μM of Bleb (lanes 5 to 8) at 5 hpi. At 8 hpi, infected cells and their medium
fractions were collected for further analyses. (A) Viral titer. Medium fractions of infected cells were collected and subjected to plaque assays. Viral titers were shown as means
with SD (n¼3). (B) Quantitative detection of vRNA. Total RNA of infected cells was puriﬁed, and the synthesis level of segment 5 vRNA was quantiﬁed by real-time PCR using
corresponding primers. Results were normalized as the ratio to those of untreated cells and presented as means with SD (n¼3). (C) Expression level of viral proteins. Infected
cells were subjected to Western blotting with anti-NP (upper panel), anti-M1 (middle panel), and anti-β-actin (lower panel) antibodies. (D) Time course analysis of the
production of infectious virions. MDCK cells infected with PR8 virus at an MOI of 3 were mock-treated (DMSO) or treated with 100 μM of CytoD or 150 μM of Bleb at 5 hpi. At 5,
8, 12, 24, and 48 hpi, the viral titers in the supernatant fractions were determined by plaque assay. n.d.: Not detected (less than 20 PFU/ml). (E) Expression level of NMII in
knocked-down cells. HeLa cells transfected with nontargeting (Control; lanes 1 to 3) or NMHC-IIA (NMII; lane 4) siRNA were lysed at 48 h post transfection. Then, the lysates
equivalent to 1.25 μg (lane 1), 2.5 μg (lane 2), and 5 μg (lanes 3 and 4) of total protein were subjected to SDS-PAGE followed by Western blotting with anti-NMHC-IIA antibody.
(F) The viral titers at 12 hpi were determined by plaque assays. Viral titers were shown as means with SD (n¼3). (G) The level of segment 5 vRNAwas quantiﬁed as described in
the legend of panel B. (H) The lysates of mock-infected (lanes 1 and 2) and infected (lanes 3 and 4) cells were subjected to Western blotting assay with anti-NP (upper panel),
anti-M1 (middle panel) and anti-β-actin (lower panel) antibodies, respectively. In panels I, J, and K, MDCK cells were treated with 0, 5, 15, 50, or 150 μM of Bleb in the absence or
presence of 20 μM of CytoD (CytoD and þCytoD, respectively). Then, the samples were collected at 8 hpi. (I) Viral titers. Medium fractions of infected cells were subjected to
plaque assays. Results in the absence (CytoD, solid line) or presence of 20 μM of CytoD (þCytoD, dash line) are represented. Results were normalized as the ratio to those in
the absence of any inhibitors and shown as means with SD (n¼4). (J) Quantitative detection of vRNA. Results were shown as means with SD (n¼4). (K) Expression level of viral
proteins. Infected cells were subjected to Western blotting with anti-NP (upper panel), anti-M1 (middle panel), and anti-β-actin (lower panel) antibodies.
containing viral membrane proteins, HA, NA, and M2. The formation
of inﬂuenza virus particle is a dynamic process including bending of
the plasma membrane outward. It has been known that HA forms
clusters at the plasma membrane by intrinsically associating with
lipid rafts (Scheiffele et al., 1997; Takeda et al., 2003), and then M1, a
viral scaffold protein, is recruited beneath the HA cluster (Ali et al.,
2000). The interaction of M1 with the plasma membrane and the
oligomerization of M1 are necessary for the alteration of membrane
curvature (Gómez-Puertas et al., 2000; Ruigrok et al., 2001). It is also
reported that viral ion channel M2 mediates the membrane scission
and virion release (Rossman et al., 2010).
Actin ﬁlament is extensively developed beneath the plasma
membrane, where inﬂuenza virus particles assemble to egress
accompanied with membrane dynamics. It has been demon-
strated that actin polymerization contributes to the morphology
of the inﬂuenza virus particles (Roberts and Compans, 1998;
Simpson-Holley et al., 2002). Super resolution imaging method
indicated that HA dynamics on the plasma membrane can be
mediated by actin polymerization (Gudheti et al., 2013). Further,
it is shown that M1 and vRNP are associated with actin ﬁlaments
(Avalos et al., 1997). Thus, these results suggest that inﬂuenza
virus assembly occur in coordination with the actin ﬁlaments
beneath plasma membrane.
Here, we investigated a role of actin-myosin network on the
virus particle assembly. The formation of highly organized actin
ﬁlament requires NMII (Heissler and Manstein, 2013; Vicente-
Manzanares et al., 2009). We examined the effect of blebbistatin
(Bleb), an inhibitor of NMII. Bleb reduced viral titer, whereas it
did not affect the synthesis levels of viral RNAs and proteins.
Furthermore, in the presence of Bleb, the export of vRNP from
the nucleus to the cytoplasm and the transport of vRNP, M1, and
HA to the plasma membrane were not affected. Scanning electron
microscopy (SEM) revealed that the plasma membrane on
infected cells when treated with Bleb exhibits a signiﬁcant
number of aggregated structures containing HA, and immuno-
ﬂuorescence assays showed ectopically accumulated HA at late
phases of infection. These aggregates seemed dead-end products
which were not allowed to form virions. Thus, we would propose
that the actin-myosin network play an important role on the viral
assembly process beneath the plasma membrane.
Fig. 2. Localization of vRNP, M1, and HA in inﬂuenza virus infected cells treated with Bleb. (A) Nuclear export of vRNP. MDCK cells were infected with PR8 virus at an MOI of
3 (panels in middle and bottom rows) or mock-infected (panels in the top row). At 5 hpi, cells were treated with DMSO (panels in top and middle rows), or 150 μM of Bleb
(panels in bottom row). At 8 hpi, cells were ﬁxed and subjected to immunoﬂuorescence assays, followed by imaging with confocal microscopy. vRNP was stained with anti-
NP monoclonal antibody that recognizes NP of vRNP (green, left column). DNA was detected with TO-PRO-3 (blue, middle column). Merged pictures are shown in the right
column. Scale bars, 10 μm. (B–D) Trafﬁcking of vRNP, M1, and HA to the plasma membrane. Conﬂuent monolayer MDCK cells were infected with PR8 virus at an MOI of 10
(panels in middle and bottom rows) or mock-infected (panels in the top row). At 5 hpi, cells were treated with DMSO (Bleb) or 150 μM of Bleb (þBleb). At 8 hpi, infected
cells were ﬁxed and subjected to immunoﬂuorescence assays with anti-NP (panel B), anti-M1 (panel C) and anti-HA (panel D) antibodies (green). F-actin was co-stained with
Alexa Fluor 568 phalloidin (red). Image reconstitutions along the z-axis were carried out. Only a single optical section in the Z plane is shown. Apical and basolateral side are
represented as open and closed arrow heads, respectively. Scale bars, 10 μm. (E) Membrane ﬂoatation assay. MDCK cells were infected with PR8 virus at an MOI of 3. At 5 hpi,
cells were treated with DMSO (lanes 1 to 4) or 150 μM of Bleb (lanes 5 to 8). At 8 hpi, postnuclear supernatants were subjected to membrane ﬂoatation assay. Lanes 2 to
4 and 6 to 8 are membrane fractions as described in materials and methods. Lanes 1 and 5 represent input. The distribution of viral and host proteins were analyzed by
Western blotting with anti-HA (top panels), anti-NP (second panels), anti-M1 (third panels), anti-β1 integrin (fourth panels), and anti-α-tubulin (bottom panels) antibodies.
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Results
Viral titer reduction by Bleb without alteration of the synthesis
of viral RNAs and proteins
To examine a role of actin ﬁlaments on the inﬂuenza virus
assembly, we tried to examine the effect of blebbistatin (Bleb) and
cytochalasin D (CytoD) on virus growth. CytoD caps actin ﬁlament
at the barbed ends, and inhibits actin polymerization, whereas
Bleb inhibits the ATPase activity of NMII leading the actin-myosin
network formation, but does not inhibit the polymerization of
actin ﬁlaments (Kovács et al., 2004; Straight et al., 2003).
At 5 h post infection (hpi), PR8-infected MDCK cells were treated
with either dimethyl sulfoxide (DMSO), a solvent of inhibitors, CytoD,
or Bleb at various concentrations. To exclude input viruses, infected
cells werewashed withMEM (pH 4.5) after infection period. Viral titers
of growth media were examined at 8 hpi to evaluate quantitatively the
effect of the actin-myosin network before reaching a plateau phase
(Fig. 1A). In the presence of CytoD (lanes 2 to 4) or Bleb (lanes 5 to 8),
viral titers showed a dose-dependent reduction. The viral titers under
treatment of 100 μM of CytoD (lane 4) and 150 μM of Bleb (lane 8)
were dropped to 16% and 4% compared with those of untreated
samples (lane 1), respectively. The synthesis level of vRNA and viral
proteins in infected cells at 8 hpi was examined by quantitative RT-PCR
(Fig. 1B) and Western blotting (Fig. 1C), respectively. Even in the
presence of either CytoD or Bleb, the vRNA synthesis level was
comparable to that in the absence of inhibitors (Fig. 1B). In addition,
any prominent reduction of viral protein synthesis in the presence of
either inhibitor was not observed (Fig. 1C). As previously reported
(Roberts and Compans, 1998; Simpson-Holley et al., 2002) and shown
in Fig. 1D, the inhibitory effects of CytoD and Bleb were not found at a
plateau phase of virus growth, suggesting that the actin-myosin
network is related to the efﬁciency of the virus production but not
rate-limiting processes.
In panels E to H, the effect of Bleb on inﬂuenza virus growth
was also examined using siRNA for non-muscle myosin heavy
chain IIA (NMHC-IIA), which is one of the NMII subunits and
essential for the assembly of actin-myosin network. The expres-
sion level of NMII was reduced to around 25% in HeLa cells treated
with siRNA (Fig. 1E, lane 4). Under this condition, the infectious
virus production was dramatically decreased at 12 hpi (Fig. 1F).
However, the expression levels of vRNA (Fig. 1G) and viral proteins
(Fig. 1H) were comparable to those in the cells treated with control
siRNA. These results were consistent with those in the presence of
Bleb, indicating that actin-myosin network is important for inﬂu-
enza virus growth.
Next, we tried to examine the effect of Bleb on inﬂuenza virus
growth at 8 hpi with or without 20 μM CytoD that caused 50%
inhibition as shown in Fig. 1A. In Fig. 1I, viral titers were normal-
ized as the ratio to that in the absence of any inhibitors (CytoD,
lane 1). In the absence of CytoD (CytoD), the viral titer was
decreased to 48% of control by adding 5 μM of Bleb (CytoD, lanes
1 and 2). In contrast, we found that Bleb has a slight effect on the
virus growth in the presence of 20 μM of CytoD (þCytoD, lanes
1 and 2). By calculating from these viral titers, IC50 of Bleb in the
presence of CytoD was higher (30.2 μM) than that in the absence
of CytoD (IC50 o5 μM). We determined combination index (CI)
using CalcuSyn software (Biosoft). The resulting CI values were
more than 1.2, suggesting that the effect of Bleb was competitively
antagonized by CytoD. The amount of vRNAs and proteins in inf-
ected cells even in the presence of both CytoD and Bleb was not
altered (Fig. 1J and K). These results suggest that the actin-myosin
network is required for a process(es) post the viral genome rep-
lication in a polymerized actin ﬁlaments-dependent manner.
Transport of vRNP, M1, and HA at late phases of infection in the
presence of Bleb
Newly synthesized vRNP complex is exported from the nucleus to
the cytoplasm together with M1 and NS2 in a CRM1-mediated
manner (Elton et al., 2001; Ma et al., 2001; Neumann et al., 2000;
O’Neill et al., 1998; Watanabe et al., 2001). After nuclear export, vRNP
is transported to the plasma membrane and then packaged into
progeny virions with viral structural proteins such as HA and M1. To
examine the effect of Bleb on the intracellular transport of viral
proteins and vRNP, we visualized intracellular localization of vRNP,
HA, and M1 at late phases of infection with Bleb treatment. MDCK
cells were mock-infected or infected with PR8 virus at a multiplicity
of infection (MOI) of 3, followed by treatment with 150 μM of Bleb at
5 hpi, which is a maximal concentration used in Fig. 1. At 8 hpi,
the cells were ﬁxed and processed for immunoﬂuorescence assays.
For staining of vRNP, we used mouse anti-NP monoclonal antibody
(mAb61A5) that recognizes NP only associated with vRNA (Momose
et al., 2007). As shown in Fig. 2A, most vRNPs were detected in the
cytoplasm of infected cells (middle panels), while no obvious ﬂuo-
rescence was found in uninfected cells (upper panels). This result
indicates that vRNP is transported to the cytoplasm under this
condition, although a majority of vRNP was found in the nucleus at
earlier time point (Jo et al., 2010 and data not shown). In infected
cells treated with Bleb, vRNPs were localized predominantly in the
cytoplasm to the same extent in untreated cells (lower panels). These
results demonstrate that newly synthesized vRNP is successfully
transported to the cytoplasm in the presence of Bleb. Next, we
examined whether Bleb inhibits the transport of viral components to
the apical plasma membrane, where progeny virions assemble and
egress. Image reconstitution from successive pictures was carried out
to show a cross-section picture along the z-axis (Fig. 2B–D). In the
middle panel in Fig. 2B, vRNP staining was merged with apical side of
the plasma membrane in infected cells in the absence of inhibitor.
The localization pattern of vRNP in infected cells in the presence of
Fig. 3. Effects of Bleb on budding of progeny virions from the plasma membrane. (A) The cell surface structure. MDCK cells were mock-infected (upper panels) or infected
(lower panels) with Udorn virus at MOI of 3. At 5 hpi, cells were treated with DMSO (left) or 150 μM of Bleb (right). At 15 h post infection, cells were ﬁxed with 2.0%
glutaraldehyde. The cell surface was observed with scanning electron microscopy (SEM). Representative pictures taken by SEM were shown. Scale bars, 1 μm. (B) The
distribution of the length of aggregated structures. The aggregated structures with more than 1 μm in the major axis were counted and represented as scatter plot. For each
analysis, 186 aggregated structures were counted. p Values were calculated by Mann–Whitney U test. (C) The population of cells with large aggregates. The percentages of
cells with aggregates with more than 7 μm in length were shown. With mock-infected cells in the absence or presence of Bleb, and infected cells in the absence or presence
of Bleb, 18, 20, 28, and 18 cells were investigated, respectively. (D) At 15 h post infection, HA on the cell surface was detected with immuno-SEM. Forty nm gold particles
observed on cell surface are indicated by open arrowheads. Scale bars, 200 nm. In panels E–G, aggregated structures of HA were detected with immunoﬂuorescence assays.
At 15 h post infection with Udorn virus, cells were ﬁxed with 4% PFA and subjected to immunoﬂuorescence assays, followed by imaging with confocal microscopy along the
z-axis. Mock-infected (panels in left column) or infected (panels in middle and right columns) cells were treated with DMSO (Bleb) or 150 μM of Bleb (þBleb). Cells were
stained with anti-HA (panels in the upper row, red) and anti-NMHC-IIA (panel E), anti-M2 (panel F), or anti-M1 (panel G) (panels in the second row, green) antibodies. The
merged images were shown in panels in the third row. The stacking images along the z-axis were obtained by Maximum intensity projection processing of ZEN 2009
software. Aggregated structures observed on Bleb-treated cell are indicated by open arrowheads. In panel G, single optical sections in the x–z plane (along dashed line) are
taken for merged ﬂuorescence images (panels in the lower row). Scale bars, 10 μm. (H) The distribution of the length of aggregated structures of HA. The aggregated
structures of HA on infected cells with the major axis more than 2 μmwere counted and represented as scatter plot. For each analysis, 120 aggregated structures of HA were
counted. p Values were calculated by Mann–Whitney U test. (I) The population of cells with large HA aggregates. The percentages of cells with HA aggregates with length
more than 7 μm were shown. For infected cells in the absence or presence of Bleb, 65 and 22 cells were investigated, respectively.
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Bleb (lower panel) was similar to that in the absence of Bleb (middle
panel). Although M1 diffusively accumulated near the plasma mem-
brane (Fig. 2C), the localization pattern of M1 in the presence of Bleb
(lower panel) was comparable to that of control infected cells (mid-
dle panel). Further, Bleb did not inhibit the typical localization patt-
ern of HA at the plasma membrane. We also conﬁrmed the transport
of viral proteins to the plasma membrane using membrane ﬂoatation
assay (Fig. 2E). The accumulation levels of HA, NP, and M1 in mem-
brane fractions of Bleb-treated cells (lanes 6 to 8) were comparable to
those in the absence of Bleb (lanes 2 to 4). Therefore, these results
demonstrate that the transport of vRNP, M1, and HA to the plasma
membrane are not affected by Bleb.
Aggregated structures containing HA on the plasma membrane
of infected cells treated with Bleb
From the results so far, it is likely that Bleb blocks a focal
assembly step(s) of inﬂuenza virus particles at or near the plasma
membrane. This hypothesis is reasonable because the actin-myo-
sin network is extensively developed beneath the plasma mem-
brane (Conti and Adelstein, 2008; Heissler and Manstein, 2013;
Vicente-Manzanares et al., 2009), where the viral particle assem-
bly and egress take place. To address this, we observed the viral
particles at the plasma membrane during budding process with
scanning electron microscope (SEM). Udorn strain was used in this
experiment to distinguish viruses from cellular microvilli since
Udorn virus shows long ﬁlamentous shape (Elleman and Barclay,
2004). The reduction of virus production from Udorn-infected cells
by Bleb treatment was similar to that of PR8 shown in Fig. 1A (data
not shown). Infected or mock-infected cells were treated with
150 μM of Bleb at 5 hpi. At 15 hpi, the cells were ﬁxed and subj-
ected to SEM observation. Fig. 3A upper panels show representa-
tive pictures of mock-infected cells treated without (left panel) or
with 150 μM of Bleb (right panel). In both cases, there was little
ﬁlamentous structure. In contrast, since we detected a number of
budding structures with ﬁlamentous shape on the surface of inf-
ected cells in the absence of Bleb (lower and left panel), it is likely
that these budding structures are progeny viral particles. As shown
in the lower and right panel, we found large aggregated structures
at the plasma membrane in the presence of Bleb. To examine the
size distribution, the length of aggregated structures with more
than 1 μm in the major axis was measured, and the results were
presented in scatter plot in Fig. 3B. As shown here, most ﬁlamen-
tous structures observed at mock-infected cells were less than
3 μm, indicating that these were cellular microvilli. In contrast, the
percentage of ﬁlamentous structures with larger than 3 μm at
infected cells were raised from 2.2% to 18.3% in the absence of
Bleb, suggesting that these were structures associated to budding
progeny virions. In Fig. 3C, we calculated the percentages of cells
with more than one aggregated structure with the major axis
longer than 7 μm. The percentages of the cells with large aggre-
gated structures were elevated to 56% on infected cells by the Bleb
treatment. In addition, immuno-SEM analysis revealed that these
aggregated structures contain HA as indicated by arrow heads
(Fig. 3D). Next, we examined the localization of HA in Udorn-
infected cells at 15 hpi by indirect immunoﬂuorescence assay
(Fig. 3E–G). To observe HA protein at the cell surface, cells were
incubated with anti-HA antibody without permeabilization. For
observation of other proteins, after ﬁxing in 4% paraformaldehyde
for 10 min, cells were permeabilized in 0.5% NP-40 and then sub-
jected to immunoﬂuorescence assay with their speciﬁc antibodies.
Reconstituted pictures along the z-axis were layered with Max-
imum intensity projection processing of ZEN 2009 software. HA
were distributed evenly at the plasma membrane of infected cells
without Bleb treatment (Fig. 3E, middle panels). In contrast, HA
formed aggregated structures in the presence of Bleb as indicated
by arrow heads (right panels). As seen in right panels, Bleb
treatment resulted in a loss of ﬁlament like structures of NMII in
comparison with those in the absence of Bleb (Fig. 3E, left and
middle panels). However, NMII did not seem to speciﬁcally
accumulate in HA aggregations. On the other hand, M2 accumu-
lated together with HA on the cell surface in the presence of Bleb
(Fig. 3F, right panels), but M1 did not (Fig. 3G, right panels). These
suggest that proper assembly of viral particles at the plasma
membrane is impaired by Bleb treatment. The image in the x–z
plane also showed aggregated HA on the surface of infected cell in
the presence of Bleb, but not inside the cell (Fig. 3G, bottom
panels). The length of HA aggregates (Fig. 3H) and the percentage
of cells with HA aggregates (Fig. 3I) were similar to the results in
Fig. 3B and C, suggesting that these HA aggregates are identical to
the aggregated structures observed by SEM.
To bend lipid bilayer for virus budding, the oligomerization
of M1 beneath the plasma membrane is required (Gómez-Puertas
et al., 2000; Ruigrok et al., 2001). M1 does not have an intrinsic
apical sorting signal, but it has been reported that M1 accumulates
beneath the plasma membrane through association with cytoplas-
mic tails of HA and NA (Ali et al., 2000). Therefore, to visualize the
signal of possible budding sites, we tried to examine the close
association of M1 with HA by proximity ligation assay (PLA) at the
plasma membrane (Jarvius et al., 2007; Söderberg et al., 2006). In
the PLA system, the theoretical maximum distance between two
target proteins is 40 nm to yield an ampliﬁed signal. PLA was
carried out with a combination of anti-HA and anti-M1 antibodies
(Fig. 4A, third rows). Using either the combination of anti-HA and
anti-NP (Fig. 4A, panels in ﬁrst rows) or that of anti-HA and pre-
immune serum (Fig. 4A, panels in second rows), the PLA signals
were hardly found. This is possibly due to an apical targeting of
vRNP mediated by M1 but not HA. Around 40% of HA signals co-
localized with PLA signals between anti-HA and anti-M1 antibo-
dies. It is noted that a part of HA located at the plasma membrane
are assembled into progeny virions at lipid rafts, where viral
membrane proteins are distributed properly and vRNP are suc-
cessfully recruited (Takeda et al., 2003; Zhang et al., 2000). By the
addition of Bleb, HA aggregation occurred (Fig. 4A, left and bottom
panel) as shown previously (Fig. 3E–G, right panels), but there
were only a few PLA signals in these aggregates shown by arrow
heads compared to the substantial amount of HA, suggesting that
these aggregated structures could not be assembled into viral
particles. These would be dead-end products. We counted the
number and the volume of PLA signals between HA and M1 using
IMARIS software in Fig. 4B and C. The number of PLA signals in the
presence of Bleb was not signiﬁcantly different from that in the
absence of Bleb (Fig. 4B). The volume of PLA signals of cells treated
with Bleb was slightly larger than that in the absence of Bleb,
although the difference was statistically signiﬁcant (po0.005)
(Fig. 4C). Based on these results, it is quite likely that the actin-
myosin network is involved in the virion assembly process of inﬂ-
uenza virus beneath the plasma membrane.
Discussion
In this study, we found that Bleb, a potent inhibitor of non-
muscle myosin II (NMII), reduced the virus titer at 8 hpi, but did
not affect the synthesis levels of viral RNAs and proteins. These
effects were conﬁrmed with NMII knock-down cells. Neither nuc-
lear export of vRNP nor intracellular transport of vRNP, M1, and HA
to the plasma membrane was altered in Bleb-treated cells. How-
ever, aggregates of HA and M2 were observed at the plasma mem-
brane in the presence of Bleb, while M1 hardly accumulated in
these structures. Taken all together, these results suggest that the
actin-myosin network play an important role in the assembly of
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inﬂuenza viral particles at the plasma membrane possibly through
control of proper viral protein assembly.
The NMII functions as a complex composed of one pair of heavy
chains and two pairs of light chains (Conti and Adelstein, 2008).
The heavy chain consists of motor, regulatory, and tail domains.
The motor domain is conserved among myosin superfamily and
required for the actin- and nucleotide-binding, whereas there are
many functional variations in the tail domain, which interacts with
target proteins (Berg et al., 2001). NMII self-assembles through
long coiled-coil region in the tail domain, while other myosin
proteins interact with cargos for their delivery (Salles et al., 2009;
Wu et al., 2002). This NMII interaction mediated by the tail domain
provides the crosslinking between actin ﬁlaments for contraction
and expansion of actin ﬁlaments. Therefore, the inhibition of inﬂ-
uenza virus proliferation by Bleb is probably due to a defect(s) in
the contraction and/or expansion of actin-myosin network, but not
by the inhibition of the cargo transport. This is consistent with our
results shown in Fig. 2.
Although detailed studies are needed to clarify the exact function
of the actin-myosin network in the virion assembly process, it is useful
to discuss possible function of the actin-myosin network in that
process. Under the plasma membrane and at the cytosolic surfaces
of intracellular vesicles, the actin-myosin network is abundantly exte-
nded to regulate numerous events coupled with the membrane dyna-
mics including exocytosis, receptor clustering, membrane protrusion,
etc. (Chichili and Rodgers, 2009; Goswami et al., 2008; Jaqaman et al.,
2011; Lillemeier et al., 2006; Papadopulos et al., 2013; Porat-Shliom
et al., 2013; Vicente-Manzanares et al., 2007). At late phases of
infection, the newly synthesized vRNP of inﬂuenza virus is transported
toward the plasma membrane along microtubules via Rab11a-dep-
endent recycling endosomes (Amorim et al., 2011; Bruce et al., 2010;
Eisfeld et al., 2011; Momose et al., 2011). Together with M1 proteins,
vRNP is then translocated to and concentrated at the budding site with
the clusters of raft-associated HA for the virus production. When the
viral components translocate to the budding sites, they need to pass
through the cell cortex consisting of highly-developed actin ﬁlaments.
Actin ﬁlaments are thought to be a physical barrier for secretory
vesicles since highly developed actin ﬁlaments within the cell cortex
inhibit the migration of vesicles (Aunis and Bader, 1988). In contrast,
the actin-myosin network is reported to contract and expand actin
ﬁlaments for the translocation of secretory vesicles to the plasma
membrane (Berberian et al., 2009). Thus, it is possible that the actin-
myosin network is important for the assembly of viral components
such as M1 and vRNP to the budding sites beneath plasma membrane.
In fact, PLA signals between HA and M1 were poorly found in HA
aggregates in the presence of Bleb (Fig. 4A). This might be due to a
defect of M1 translocation to the budding sites properly.
After transport to the apical plasma membrane, HA accumu-
lates in lipid rafts via a targeting signal in the cytoplasmic tail
domain. The raft-associated HA proteins are clustered through the
assembly of small rafts at the plasma membrane to be enriched on
the surface of viral particles (Kenworthy and Edidin, 1998; Veit and
Fig. 4. Effect of Bleb on the proximal positioning of HA and M1 at the plasma membrane. Infected MDCK cells were prepared as shown in Fig. 3E–G, before staining
procedures, followed by PLA assays for detection of the proximity of HA with M1. At 5 hpi, the cells were treated with DMSO (Bleb) or 150 μM of Bleb (þBleb). (A) PLA
signals at HA aggregates. PLA assays were carried out using anti-HA together with anti-NP (panels in the top row), rabbit pre-immune serum (panels in the second row), or
anti-M1 (panels in third and fourth rows) antibodies. Immunostaining signals of HA (green), PLA (red), and merged images are presented in panels in left, middle, and right
columns, respectively. These are obtained by Maximum intensity projection processing. Aggregated structures of HA observed on Bleb-treated cell are indicated by open
arrowheads. Scale bars, 10 μm. (B) The number of PLA signals. In the absence or presence of Bleb, the number of PLA signals in 14 and 13 infected cells were counted,
respectively. The results were shown as mean number per cell with SD. The level of signiﬁcance was determined by Welch’s t-test. (C) The volume of PLA signals. The volume
of each PLA signal was measured using IMARIS software. Randomly chosen 200 PLA signals were represented as scatter plot. The level of signiﬁcance was calculated by
Mann–Whitney U test.
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Thaa, 2011). The cortical actin including the actin-myosin network
appears to conﬁne the zone for the diffusion of raft-associated
receptors and increase the rate of protein collision for clustering
(Jaqaman et al., 2011). In addition, it has been reported that the
clustering and distribution of HA is altered by potent inhibitors of
actin polymerization and depolymerization of actin ﬁlaments
(Gudheti et al., 2013; Simpson-Holley et al., 2002). However, M2
was also accumulated with HA aggregates on the surface of Bleb-
treated cells (Fig. 3F). A study using ﬂuorescence life time imaging
microscopy-ﬂuorescence resonance energy transfer (FLIM-FLET)
revealed that M2 is not co-localized with HA that is unable to
cluster (Thaa et al., 2010). Therefore, it is possible that the raft
clustering and M2 association of HA are not controlled by the
actin-myosin network.
For budding of viral particles, the plasma membrane should be
remodeled by changing membrane curvature and constructing pr-
otrusions. It has been assumed that the membrane curvature is
changed by the oligomerization of M1 beneath the plasma
membrane (Gómez-Puertas et al., 2000; Ruigrok et al., 2001).
Previously it has been shown that the pinching off of virus par-
ticles from the plasma membrane is mediated by M2, which is a
viral membrane protein located at the boundary between raft and
non-raft microdomains. The actin-myosin network organizes ter-
minal web structures of actin ﬁlaments at the base region of pro-
trusion. Using the actin-myosin network as a scaffold, it is ass-
umed that actin ﬁlaments are polymerized to be a motive force for
the formation of membrane protrusion (Kolega, 2006; Verkhovsky
et al., 1995; Xue et al., 2010). Similarly, it is reported that budding
of a ﬁlamentous inﬂuenza virus requires polymerization of actin
ﬁlaments (Simpson-Holley et al., 2002). Thus, in addition to the
membrane rearrangements by viral proteins, the actin-myosin
network may control the membrane protrusion for viral particle
formation.
It is known that the membrane receptor clustering in lipid rafts
at the cell surface by the interaction of receptors with their ligands
induce the rearrangement of actin ﬁlaments, leading to endocytosis,
stress ﬁber formation, and so on (Goswami et al., 2008; Jaqaman
et al., 2011). In infected cells, HA as well as other viral proteins are
highly expressed (Numajiri Haruki et al., 2011). The raft-associated
HA cluster on the plasma membrane subsequently induce the Raf/
MEK/ERK signaling pathway, probably due to the activation of
Gα12/13, which can give rise to several signals regulating the
actin-myosin network (Haidari et al., 2011; Marjuki et al., 2006). It
has also been demonstrated that inﬂuenza virus enhances poly-
merization of actin ﬁlaments and formation of ﬁber-like NMII
(Haidari et al., 2011). Collectively, it is conceivable that highly
expressed HA anchored at the plasma membrane may trigger the
alteration of actin ﬁlaments including rearrangement of the actin-
myosin network. Using rearranged actin-myosin network triggered
by infection stimulus, the virus particle assembly takes place.
Materials and methods
Biological materials
Inﬂuenza A/Puerto Rico/8/34 (PR8, H1N1) and A/Udorn/72
(Udorn, H3N2) viruses were propagated at 35 1C for 48 h in allantoic
sacs of 11-day-old embryonated chicken eggs and the virus titer was
determined by plaque assay (Takizawa et al., 2010). Rabbit poly-
clonal antibody against NP and M1 were generated as previously
described (Kawaguchi et al., 2011; Takizawa et al., 2006). Anti-NP
mouse monoclonal antibody (mAb61A5) and rabbit pre-immune
serum were kind gifts of F. Momose (Kitasato University). Anti-β1
integrin antibody was generously provided by Y. Kanaho (University
of Tsukuba). Anti-HA monoclonal antibodies derived from Clones
C179 and F49 were purchased from TaKaRa and used for detection
of HA of PR8 and Udorn viruses, respectively. Anti-β-actin, anti-α-
tubulin, and anti-non-muscle myosin heavy chain IIA (NMHC-IIA)
antibodies were purchased from Sigma. Anti-M2 antibody was
purchased from abcam. MDCK and HeLa cells were maintained in
minimum essential medium (MEM, Sigma) supplemented with 10%
fetal bovine serum at 37 1C with 5% CO2. Cytochalasin D (CytoD) and
Bleb were purchased from Sigma.
Quantiﬁcation of vRNA expression level
Isolated total RNAs were reverse-transcribed with a primer (50-
GACGATGCAACGGCTGGTCTG-30) that corresponds to segment 5 cRNA
between nucleotide sequence positions 424 and 444. The synthe-
sized single-stranded cDNAs were subjected to quantitative real-time
PCR analysis (Dice real-time thermal cycler system TP800; TaKaRa)
with two speciﬁc primers, 50-GACGATGCAACGGCTGGTCTG-30 which
corresponds to segment 5 cRNA between nucleotide sequence po-
sitions 424 and 444, and 50-AGCATTGTTCCAACTCCTTT-30 which is
complementary to the segment 5 cRNA between nucleotide seque-
nce positions 595 and 614.
Gene silencing mediated by siRNA
Control and NMHC-IIA siRNAs were obtained from Invitrogen.
HeLa cells (5105) were transfected with 30 pmol of siRNA using
Lipofectamine RNAi MAX (Invitrogen) according to the manufac-
turer’s instructions.
Combination index
Combination index of Bleb and CytoD treatment for viral titer was
determined by the Chou-Talalay method using CalcuSyn software
(Biosoft, Cambridge, UK). A combination indexo0.9, ¼0.9 to 1.1,
41.1 indicate synergism, additivity, and antagonism, respectively.
Indirect immunoﬂuorescence
Infected MDCK cells were washed with PBS, ﬁxed with 4%
paraformaldehyde (PFA) for 15 min, and permeabilized with 0.5%
Nonidet P-40 (NP-40) for 5 min. After incubation in PBS supple-
mented with 1% skim milk for 30 min, indirect immunoﬂuores-
cence assays were performed with speciﬁc antibodies and Alexa
Fluor 488- or 568-conjugated anti-rabbit and -mouse IgG anti-
bodies. At the same time, nucleus and F-actin were stained with
TO-PRO-3 iodide and Alexa Fluor 568 phalloidin, respectively.
Images were acquired by confocal laser scanning microscopy
LSM-700 and subsequently analyzed by ZEN 2009 software (Carl
Zeiss). For analysis of viral protein transport to the plasma mem-
brane, serial planes of micrograph were captured along the depth
of the cell to generate z-axis reconstitutions using orthogonal
algorithm in ZEN 2009 software. To avoid the intracellular staining
of HA such as that at Golgi apparatus, anti-HA antibody was used
without permeabilization for the indirect immunostaining experi-
ments of cells infected with Udorn virus.
Membrane ﬂoatation assay
To analyze protein association to the membrane, we carried out
membrane ﬂoatation assay (Ali et al., 2000). Brieﬂy, infected cells
scraped from dishes were suspended with an ice-cold hypotonic
lysis buffer (10 mM of Tris, pH 7.9, 10 mM of KCl, 5 mM of MgCl2).
Cell suspensions were incubated on ice for 30 min before disrup-
tion by 25 passages through a 27-ga needle. Unbroken cells and
nuclei were removed by centrifugation at 1000 g for 5 min at
4 1C. The resulting supernatant fractions (0.4 ml) were mixed with
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2.0 ml of 75% (wt/wt) sucrose in low-salt buffer (LSB; 10 mM of
Tris, pH 7.9, 25 mM of KCl, 5 mM of MgCl2). Then, 2.0 ml of the
mixture were transferred to 5 ml ultracentrifuge tubes. Samples
were subsequently overlaid with 2.5 ml of 55% and 0.6 ml of 5%
sucrose in LSB. The tubes were ultracentrifuged at 38,000 rpm for
18 h at 4 1C using Optima L-90K ultracentrifuge and SW55Ti rotor
(Beckmann courter). After centrifugation, 12 fractions (0.4 ml)
were collected from the top, and 3 lightest fractions containing
plasma membrane were subjected to Western blotting analysis.
Scanning electron microscope (SEM)
MDCK cells on cover slips were prepared in the same way as the
immunoﬂuorescence assay. Infected cells were subsequently ﬁxed
with 2.0% glutaraldehyde. After further ﬁxation with OsO4 for 1 h,
sequential dehydrations with ethanol in a step-wise manner were
carried out. Then, buffer was exchanged with tert-butyl alchole. The
sample was freeze-dried for 24 h, followed by mounting on a metal
base. Finally, the sample was subjected to platinum coating for
giving an electrical conductivity. The samples were observed on SEM
JSM-6320F (JEOL). Images were put in print through a thermal
imager FTI-500 (Fujiﬁlm). For measurement of the length of aggre-
gated structures and counting the number of aggregates, the
pictures of SEM images were taken at 10,000 magniﬁcation. For
immuno-SEM, cells were ﬁrstly ﬁxed with 4% PFA. After blocking
with 1% BSA for 30 min, the cells were incubated with anti-HA (F49)
monoclonal antibody for 1 h. Then, the samples were immuno-
labeled with anti-mouse IgG coupled to 40-nm gold particles
(BioAssay Works) for 1 h. The samples were ﬁxed with 2.0%
glutaraldehyde, followed by preparation as is the case in normal
SEM. The pictures of immuno-SEM images were taken at 40,000
magniﬁcation.
Proximity ligation assay (PLA)
Infected MDCK cells on coverslip were ﬁxed with 4% PFA,
followed by blocking with 1% milk for 30 min. The cells were
incubated with anti-HA antibody for 1 h and ﬁxed again. Then, the
cells were permeabilized with 0.5% NP-40 for 5 min, subjected to
blocking, and incubated with either anti-M1 or anti-NP rabbit
polyclonal antibody for 1 h. PLA was carried out using Duolink
In Situ PLA kit (Olink Bioscience) according to the manufacturer’s
instruction. To compare with HA localization, the cells were then
incubated with Alexa Fluor 488-conjugated anti-mouse IgG. The
cells were mounted on slide glasses and observed as is the case in
the immunoﬂuorescence assay.
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